← Leaderboards
Spencer B King
Emory University
$879,207
Attributed
$879,207
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$879,207 · 2
By mechanism
M01$879,207 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Dominique L. Musselman$5,001,306
- Shanthi Vasudevan Sitaraman$3,484,505
- Tracy L Faber$2,884,987
- James L Madara$6,459,656
- Steven J Garlow$1,434,812
Others in their field
Top investigators on “Adenosine Diphosphate”
- Vincent C. Hascall · Cleveland Clinic Foundation$9,196,248
- Lewis C Becker · Johns Hopkins University$6,939,941
- Valina L. Dawson · Johns Hopkins University$6,900,753
- Ted M. Dawson · Johns Hopkins University$6,741,570
- Anthony K L Leung · Boston Children'S Hospital$5,852,009
- Bernard M Ravina · University Of Rochester$5,331,331
Research focus
Adenosine DiphosphateClinical ResearchDiagnostic CatheterizationDosageHuman SubjectHuman Therapy EvaluationPlatelet Aggregation InhibitorsPurinergic ReceptorDrug Screening /EvaluationAspirinHeart CatheterizationCoronary ArteryCoronary DisorderHeart Disorder DiagnosisOral AdministrationDrug Administration Rate /Duration
Grant awards (6)
INHIBITION OF PLATELET ADENOSINE IN PATIENTS WITH CORONARY ARTERY DISEASE$293,069
M01 · FY2002 · RR
INHIBITION OF PLATELET ADENOSINE IN PATIENTS WITH CORONARY ARTERY DISEASE$293,069
M01 · FY2002 · RR
CLOPIDOGREL THERAPY IN HEART CATHETERIZATION$0
M01 · FY2002 · RR
CLOPIDOGREL THERAPY IN HEART CATHETERIZATION$0
M01 · FY2002 · RR
INHIBITION OF PLATELET ADENOSINE IN PATIENTS WITH CORONARY ARTERY DISEASE$293,069
M01 · FY2001 · RR
CLOPIDOGREL THERAPY IN HEART CATHETERIZATION$0
M01 · FY2001 · RR